Company Monitoring Page for Astellas

latest headlines for company on cafepharma

Merck, Seagen and Astellas Get Late-Stage Win in Bladder Cancer with Combo
BioSpace
Fri, 09/22/23 - 11:53 am
Tags:
Merck, Seagen, Astellas, urothelial cancer, clinical trials, bladder cancer, Padcev, Keytruda
Taysha ends work on gene therapy after Astellas walks away, FDA requests randomized trial
Fierce Biotech
Wed, 09/20/23 - 08:47 am
Tags:
Astellas, Taysha Gene Therapies, gene therapy, FDA
Iveric Bio Announces Positive 24-Month Topline Results from Phase 3 Study of Izervay for Geographic Atrophy
PR Newswire
Tue, 09/19/23 - 10:28 am
Tags:
Astellas, clinical trials, Izervay, geographic atrophy
EU clears review of Xtandi in earlier-stage prostate cancer
Pharmaphorum
Wed, 09/13/23 - 06:02 pm
Tags:
EMA, Europe, Astellas, Pfizer, prostate cancer, Xtandi
Astellas withdraws lawsuit challenging Medicare drug price negotiation plans
Reuters
Thu, 09/7/23 - 10:44 am
Tags:
Astellas, Medicare, prostate cancer, Xtandi, drug pricing, Inflation Reduction Act
The Biopharma Patent Cliff: 9 Drugs Losing Exclusivity by the End of 2023
BioSpace
Wed, 08/23/23 - 11:11 am
Tags:
patent cliff, patents, Takeda, Vyvanse, Pfizer, Eraxis, JNJ, Stelara, Merck, Isentress, Eiger Pharmaceuticals, Zokinvy, Astellas, Myrbetriq, Novartis, Entresto, Amgen, Otzela
The 10 drugs that CMS might wrangle into negotiations
Beckers Hospital Review
Wed, 08/16/23 - 10:16 am
Tags:
CMS, Medicare, drug pricing, Bristol Myers Squibb, Janssen, Merck, Pfizer, Amgen, Boehringer Ingelheim, Pharmacyclics, AstraZeneca, Astellas, GSK
Astellas to Open New Life Sciences Facility in DivcoWest's Cambridge Crossing Neighborhood
PR Newswire
Wed, 08/9/23 - 10:36 pm
Tags:
Astellas, Cambridge MA, R&D
Iveric drug approved for type of vision loss as rival’s safety draws scrutiny
BioPharma Dive
Sun, 08/6/23 - 09:25 pm
Tags:
Iveric Bio, geographic atrophy, FDA, Izervay, Astellas
Go or no go? Biogen and Astellas head towards key PDUFAs
EP Vantage
Sat, 07/29/23 - 10:45 pm
Tags:
FDA, Astellas, Zimura, Biogen, SAGE Therapeutics, zuranolone, major depressive disorder, postpartum depression, geographic atrophy
Astellas notches another protein degrader pact with $21M upfront for PeptiDream
Fierce Biotech
Tue, 07/25/23 - 10:08 am
Tags:
Astellas, protein degradation, PeptiDream
Astellas' Zolbetuximab Is a Promising Therapy for HER2-Negative Gastric Cancer
Xtalks
Mon, 07/17/23 - 06:54 pm
Tags:
Astellas, zolbetuximab, gastric cancer, FDA, EMA
Astellas buys rights to 4D Molecular’s technology in latest gene therapy deal
BioPharma Dive
Mon, 07/10/23 - 09:34 pm
Tags:
Astellas, 4D Molecular Therapeutics, gene therapy, viral vectors
Astellas to withhold prostate cancer drug from contract pharmacies
Beckers Hospital Review
Thu, 07/6/23 - 10:03 pm
Tags:
Astellas, 340B, Xtandi, prostate cancer
Biopharma buyouts bounce back
EP Vantage
Wed, 07/5/23 - 10:17 am
Tags:
M&A, Amgen, Astellas, Eli Lilly, GSK, Horizon Therapeutics, Merck, Novartis, Pfizer, Seagen
Astellas reports data from Phase IIIb trial to treat VMS due to menopause
Clinical Trials Arena
Wed, 06/28/23 - 09:58 am
Tags:
Astellas, clinical trials, fezolinetant, hot flashes, menopause
Mimetas and Astellas expand partnership to include automation and application support
Biopharma Reporter
Tue, 06/27/23 - 10:27 pm
Tags:
Mimetas, organ-on-a-chip, Astellas, automation
Astellas delves deeper into protein degrading drugs with Cullgen deal
BioPharma Dive
Thu, 06/15/23 - 09:55 am
Tags:
Astellas, Cullgen, protein degradation
Biotech M&A is picking back up - here are the latest deals
BioPharma Dive
Tue, 06/13/23 - 11:37 am
Tags:
Novartis, Chinook Therapeutics, Paratek, Sobi, CTI BioPharma, Astellas, Iveric Bio, Assertio Holdings, Spectrum Pharmaceuticals, Merck, Prometheus Biosciences, Pfizer, Seagen, Sanofi, Provention Bio, Sun Pharma, Concert Pharmaceuticals, BioNTech, InstaDeep, AstraXeneca, CinCor Pharma, Ipsen, Albireo, Chiesi, Amryt, Moderna Therapeutics, OriCiro Genomics
With Iveric Bio buyout, Astellas CEO Okamura acted on the company's mantra to be 'aggressive'
Fierce Pharma
Tue, 06/13/23 - 10:43 am
Tags:
Astellas, M&A, Iveric Bio, Naoki Okamura, Pharma CEOs

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.